Cargando…
Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides
Viruses have killed and infected millions of people across the world. It causes several chronic diseases like COVID-19, HIV, and hepatitis. To cope with such diseases and virus infections, antiviral peptides (AVPs) have been applied in the design of drugs. Keeping in view the significant role in pha...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148704/ https://www.ncbi.nlm.nih.gov/pubmed/37359746 http://dx.doi.org/10.1007/s11831-023-09933-w |
_version_ | 1785035030067675136 |
---|---|
author | Ali, Farman Kumar, Harish Alghamdi, Wajdi Kateb, Faris A. Alarfaj, Fawaz Khaled |
author_facet | Ali, Farman Kumar, Harish Alghamdi, Wajdi Kateb, Faris A. Alarfaj, Fawaz Khaled |
author_sort | Ali, Farman |
collection | PubMed |
description | Viruses have killed and infected millions of people across the world. It causes several chronic diseases like COVID-19, HIV, and hepatitis. To cope with such diseases and virus infections, antiviral peptides (AVPs) have been applied in the design of drugs. Keeping in view the significant role in pharmaceutical industry and other research fields, identification of AVPs is highly indispensable. In this connection, experimental and computational methods were proposed to identify AVPs. However, more accurate predictors for boosting AVPs identification are highly desirable. This work presents a thorough study and reports the available predictors of AVPs. We explained applied datasets, feature representation approaches, classification algorithms, and evaluation parameters of performance. In this study, the limitations of the existing studies and the best methods were emphasized. Provided the pros and cons of the applied classifiers. The future insights demonstrate efficient feature encoding approaches, best feature optimization schemes, and effective classification techniques that can improve the performance of novel method for accurate prediction of AVPs. |
format | Online Article Text |
id | pubmed-10148704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-101487042023-05-01 Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides Ali, Farman Kumar, Harish Alghamdi, Wajdi Kateb, Faris A. Alarfaj, Fawaz Khaled Arch Comput Methods Eng Review Article Viruses have killed and infected millions of people across the world. It causes several chronic diseases like COVID-19, HIV, and hepatitis. To cope with such diseases and virus infections, antiviral peptides (AVPs) have been applied in the design of drugs. Keeping in view the significant role in pharmaceutical industry and other research fields, identification of AVPs is highly indispensable. In this connection, experimental and computational methods were proposed to identify AVPs. However, more accurate predictors for boosting AVPs identification are highly desirable. This work presents a thorough study and reports the available predictors of AVPs. We explained applied datasets, feature representation approaches, classification algorithms, and evaluation parameters of performance. In this study, the limitations of the existing studies and the best methods were emphasized. Provided the pros and cons of the applied classifiers. The future insights demonstrate efficient feature encoding approaches, best feature optimization schemes, and effective classification techniques that can improve the performance of novel method for accurate prediction of AVPs. Springer Netherlands 2023-04-29 /pmc/articles/PMC10148704/ /pubmed/37359746 http://dx.doi.org/10.1007/s11831-023-09933-w Text en © The Author(s) under exclusive licence to International Center for Numerical Methods in Engineering (CIMNE) 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Ali, Farman Kumar, Harish Alghamdi, Wajdi Kateb, Faris A. Alarfaj, Fawaz Khaled Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title | Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title_full | Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title_fullStr | Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title_full_unstemmed | Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title_short | Recent Advances in Machine Learning-Based Models for Prediction of Antiviral Peptides |
title_sort | recent advances in machine learning-based models for prediction of antiviral peptides |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148704/ https://www.ncbi.nlm.nih.gov/pubmed/37359746 http://dx.doi.org/10.1007/s11831-023-09933-w |
work_keys_str_mv | AT alifarman recentadvancesinmachinelearningbasedmodelsforpredictionofantiviralpeptides AT kumarharish recentadvancesinmachinelearningbasedmodelsforpredictionofantiviralpeptides AT alghamdiwajdi recentadvancesinmachinelearningbasedmodelsforpredictionofantiviralpeptides AT katebfarisa recentadvancesinmachinelearningbasedmodelsforpredictionofantiviralpeptides AT alarfajfawazkhaled recentadvancesinmachinelearningbasedmodelsforpredictionofantiviralpeptides |